Polarean Imaging PLC Ordinary Shares (LSE:POLX) - Share price

Stock Report

Polarean Imaging PLC POLX

Last Price

Day Change

As of 27/06/2022
16:14:29 BST | GBX
Minimum 15 Minutes Delay.

Last Close47.00p
Day Range45.00 - 47.14
Mkt Cap99.85Mil
52-Wk Range35.00 - 113.00
Yield %-

Share Price

Total Returns 27/06/2022

 Chg (%)  
More ...
Polarean Imaging PLC-51.32 
FTSE 100 TR GBP5.58
More ...
Income Statement
Operating Profit-6.01-6.62-14.32
Net Profit-6.10-6.54-14.02
Reported EPS-0.06-0.04-0.07
Balance Sheet
Current Assets3.157.6131.27
Non Current Assets3.893.273.26
Total Assets7.0410.8834.53
Current Liabilities1.891.521.97
Total Liabilities2.452.152.79
Total Equity4.598.7331.74
Cash Flow
Operating Cash Flow-4.57-5.80-12.25
Net Change in Cash1.094.3222.59

Regulatory News

DateAuthor Headline
17/01/2019David Brenchley UK Domestic Stocks to Weather Brexit Britain
UK stocks have been heavily sold off thanks to Brexit uncertainty, particularly those exposed to the domestic economy. But this throws up value opportunities
19/07/2018Hortense Bioy, CFA Top Rated Funds Best Placed to Profit in a Low Carbon World
Analysts reveal the top rated funds that invest in stocks which will be least impacted by the transition to a low-carbon economy
06/06/2018David Brenchley Fund Managers Continue to Back Facebook
While some investors were busy disposing of their stakes in Facebook after the Cambridge Analytica scandal, others took the opportunity to top up their exposure
Director Dealings
More ...
11/10/2021PurchaseMr. Cyrille Yann Nicolas Petit53.00150,00079,500.00
11/10/2021PurchaseMr. Richard Hullihen47.00153,06071,938.00
11/10/2021PurchaseDr. Jonathan Allis53.00150,00079,500.00

Company Profile

Polarean Imaging PLC designs and manufactures equipment to produce hyperpolarized xenon or helium gas. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and Grants. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.


Medical Devices


FTSE AIM All-Share

Next Event 29/06/2022

Annual General Meeting
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
Op Mrgn-12.08
EPS Grwth0.00
More ...
Record Datet.b.c.t.b.c.
More ...
Non-Executive DirectorMr. Cyrille Yann Nicolas Petit
Executive Director, Chief Financial OfficerMr. Charles Fremont Osborne Jr
Non-Executive DirectorMr. Frank Maria Schulkes
Executive Director, Chief Executive OfficerMr. Richard Hullihen
Non-Executive Director, ChairmanMr. Kenneth West
Executive Director, Chief Technology OfficerMr. Bastiaan Driehuys
Non-Executive DirectorMr. Juergen Laucht
Non-Executive DirectorMr. Daniel Myron Brague
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.